Quantbot Technologies LP Morpho Sys Ag Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$4.51 - $7.39 $4,961 - $8,129	-1,100 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$9.08 - $12.45 $908 - $1,245	-100 Reduced 8.33%	1,100 $10,000
Q3 2021 Nov 09, 2021	BUY	$11.76 - $19.51 $14,112 - $23,412	1,200 New	1,200 $14,000
Q4 2020 Feb 12, 2021	SELL	$24.81 - $30.33 $9,924 - $12,132	-400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$30.28 - $35.72 $12,112 - $14,288	400 New	400 $12,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.